Gemcitabine, capecitabine, and tislelizumab in recurrent/metastatic nasopharyngeal carcinoma following prior anti-PD-1 therapy failure: A retrospective study

Autor:	Yang, Rui, Li, Ruichen, Niu, Xiaoshuang, Zhao, Yang, Yan, Li, Tian, Shu, Zhu, Yi, Qiu, JianJian, Wang, Xiaoshen
Zdroj:	In Oral Oncology November 2024 158
Databáze:	ScienceDirect
Externí odkaz:	Zobrazit plný text záznamu Full Text from ScienceDirect